Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression

被引:0
作者
Bun'kova, K. M. [1 ]
机构
[1] IM Sechenov Med Acad, Moscow, Russia
来源
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2008年 / 108卷 / 03期
关键词
depression; psychopharmacotherapy; predictors; antidepressants;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The open comparative study of three antidepressants with different mechanisms of action - clomipramine, pirlindole and escitalopram - in the treatment of neurotic level depression (ICD-10 items F32-F34, F43) has been carried out. Ninety-one patients have been stratified into three groups included 31, 31 and 29 patients, respectively.. Duration of the study has been 12 weeks. Clomipramine, pirlindole and escitalopram have similar effect decreasing the total HAM-D score by more than 50% (in average 72%). Clomipramine appears to be more effective in the achievement of remission (63%) as compared to pirlindole (40%) and escitalopram (42%). The tolerability of pirlindole and escitalopram is higher than that of clomipramine and the authors recommend prescription of these drugs to patients with neurotic depression.
引用
收藏
页码:29 / 32
页数:4
相关论文
共 8 条
  • [1] Angst J, 1997, J CLIN PSYCHIAT, V58, P6
  • [2] COWEN PJ, 2005, ADV PSYCHIAT TREATME, V11, P19
  • [3] Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression
    Dunner, David L.
    Rush, A. John
    Russell, James M.
    Burke, Michael
    Woodard, Stacy
    Wingard, Peggy
    Allen, John
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (05) : 688 - 695
  • [4] The prevalence, clinical relevance, and public health significance of subthreshold depressions
    Judd, LL
    Schettler, PJ
    Akiskal, HS
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2002, 25 (04) : 685 - +
  • [5] Pharmacotherapy for chronic depression
    Kocsis, JH
    [J]. JOURNAL OF CLINICAL PSYCHOLOGY, 2003, 59 (08) : 885 - 892
  • [6] NORMAN L, 2005, PSYCHOTROPIC DRUGS, P164
  • [7] Thase ME, 2003, J CLIN PSYCHIAT, V64, P3
  • [8] A review of studies of the Hamilton depression rating scale in healthy controls - Implications for the definition of remission in treatment studies of depression
    Zimmerman, M
    Chelminski, I
    Posternak, M
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2004, 192 (09) : 595 - 601